Hostname: page-component-77f85d65b8-5ngxj Total loading time: 0 Render date: 2026-04-18T23:46:58.942Z Has data issue: false hasContentIssue false
  • English
  • Français

Twenty-seven years of primary salivary gland carcinoma in Wales: an analysis of histological subtype and associated risk factors

Published online by Cambridge University Press:  10 January 2022

D Leopard ,
E El-Hitti ,
P Puttasiddaiah ,
R Mcleod  and
D Owens
D Leopard*
Affiliation:
Department of Otolaryngology, Morriston Hospital, Swansea, UK
E El-Hitti
Affiliation:
Department of Otolaryngology, Princess of Wales Hospital, Bridgend, UK
P Puttasiddaiah
Affiliation:
Department of Otolaryngology, Morriston Hospital, Swansea, UK
R Mcleod
Affiliation:
Department of Otolaryngology, University Hospital of Wales, Cardiff, Wales, UK
D Owens
Affiliation:
Department of Otolaryngology, University Hospital of Wales, Cardiff, Wales, UK
*
Author for correspondence: Dr D Leopard, Department of Otolaryngology, Morriston Hospital, Heol Maes Eglwys, Swansea SA6 6NL, Wales, UK E-mail: Dan.leopard@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective

Risk factors for salivary gland carcinoma are poorly understood. Although links between background radiation, smoking and obesity have been previously suggested, no studies have so far established any significant results. This study aimed to establish correlations between common environmental and lifestyle risk factors and different subtypes of salivary gland carcinoma.

Method

A study of population data in Wales spanning 27 years was conducted; 2 national databases were used to identify 356 cases of primary salivary gland carcinoma over this period. Histological subtype of cancer and geographical location of each case was recorded. Public health data was used to establish radon levels, smoking, obesity and activity levels of populations in each geographical location. A population matched multivariate analysis of variance analysis was performed using histological subtype and risk factor data for each geographical location.

Results

A significantly higher incidence of mucoepidermoid cancer in populations with higher background radon levels (p = 0.006), epithelial-myoepithelial cancer in populations with higher smoking levels (p = 0.029) and adenoid cystic cancer in populations with higher obesity levels (p = 0.028) was found.

Conclusion

To the authors’ knowledge, this is the first study to establish significant links between background radiation, smoking and obesity with different subtypes of salivary gland carcinoma.

Keywords

Salivary GlandsParotid GlandSubmandibular GlandNeoplasmsRiskRadonRadiationSmokingObesity

Information

Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 136 , Issue 2 , February 2022 , pp. 167 - 172
Copyright
Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of J.L.O. (1984) LIMITED.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Footnotes

Dr D Leopard takes responsibility for the integrity of the content of the paper

References

Roland, NJ, McRae, RDR and McCombe, AW. Salivary gland neoplasm. In: Key Topics in Otolaryngology. Stuttgart: Thieme, 2019;364–68Google Scholar
Radoï, L, Barul, C, Menvielle, G, Carton, M, Matrat, M, Sanchez, M et al. Risk factors for salivary gland cancers in France: results from a case-control study, the ICARE Study. Oral Oncol 2018;80:56–63CrossRefGoogle ScholarPubMed
Boukheris, H, Ron, E, Dores, GM, Boukheris, H, Ron, E, Dores, GM. Risk of radiation-related salivary gland carcinomas among survivors of Hodgkin lymphoma: a population-based analysis. Cancer 2008;113:3153–9CrossRefGoogle ScholarPubMed
Chowdhry, AK, McHugh, C, Fung, C, Dhakal, S, Constine, LS, Milano, MT. Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphoma. Cancer 2015;121:1436–45CrossRefGoogle Scholar
Wilson, RT, Moore, LE, Dosemeci, M. Occupational exposures and salivary gland cancer mortality among African American and white workers in the United States. J Occup Environ Med 2004;46:287–97CrossRefGoogle ScholarPubMed
Pan, SY, de Groh, M, Morrison, H. A Case-control study of risk factors for salivary gland cancer in Canada. J Cancer Epidemiol 2017;2017:4909214CrossRefGoogle ScholarPubMed
Sadetzki, S, Oberman, B, Mandelzweig, L, Chetrit, A, Ben-Tal, T, Jarus-Hakak, A et al. Smoking and risk of parotid gland tumors: a nationwide case-control study. Cancer 2008;112:1974–82CrossRefGoogle ScholarPubMed
Muscat, JE, Wynder, EL. A case/control study of risk factors for major salivary gland cancer. Otolaryngol Head Neck Surg 1998;118:195–8CrossRefGoogle Scholar
Krewski, D, Lubin, JH, Zielinski, JM, Alavanja, M, Catalan, VS, Field, RW et al. Residential radon and risk of lung cancer: a combined analysis of 7 North American case-control studies. Epidemiology 2005;16:137–45CrossRefGoogle ScholarPubMed
Schoenberg, JB, Klotz, JB, Wilcox, HB, Nicholls, GP, Gil-del-Real, MT, Stemhagen, A et al. Case-control study of residential radon and lung cancer among New Jersey women. Cancer Res 1990;50:6520–4Google ScholarPubMed
Turner, MC, Krewski, D, Chen, Y, Pope, CA 3rd, Gapstur, SM, Thun, MJ. Radon and nonrespiratory mortality in the American Cancer Society cohort. Am J Epidemiol 2012;176:808–14CrossRefGoogle ScholarPubMed
Steinhausler, F. Current concepts in radon risk management for members of the public 1993. Salzburg: Institute of Physics and Biophysics, 1993;49Google Scholar
National Research Council. Health effects of exposure to radon. BEIR VI (Vol. 6). Washington, DC: National Academies Press, 1999Google Scholar
Darby, SC, Radford, EP, Whitley, E. Radon exposure and cancers other than lung cancer in Swedish iron miners. Environ Health Perspect 1995;103(suppl 2):45–7Google ScholarPubMed
Miller, AS, Harwick, RD, Alfaro-Miranda, M, Sundararajan, M. Search for correlation of radon levels and incidence of salivary gland tumors. Oral Surg Oral Med Oral Pathol 1993;75:58–63CrossRefGoogle ScholarPubMed
Kreuzer, M, Walsh, L, Schnelzer, M, Tschense, A, Grosche, B. Radon and risk of extrapulmonary cancers: results of the German uranium miners' cohort study, 1960–2003. Br J Cancer 2008;99:1946–53CrossRefGoogle ScholarPubMed
Welsh Government. Population estimates by local authority and age. Stats Wales. In: https://statswales.gov.wales/Catalogue/Population-and-Migration/Population/Estimates/Local-Authority/populationestimates-by-localauthority-year [18 June 2020]Google Scholar
Miller, CA, Rees, DM. Radon in homes in Wales (data report). Chilton, Public Health England Centre for Radiation, Chemical and Environmental Hazards, 2016;5Google Scholar
Public Health Wales Observatory. Results from the Welsh Health Survey at Upper Super Output Area (USOA) level. In: http://www2.nphs.wales.nhs.uk:8080/pubhobservatoryprojdocs.nsf/MainFrameset?OpenFrameSet&Frame=Right&Src=%2Fpubhobservatoryprojdocs.nsf%2F61c1e930f9121fd080256f2a004937ed%2F7d1c04e2fad3391b802579d00033e1f0%3FOpenDocument%26AutoFramed [21 June 2020]Google Scholar
Krane, JF, Farquin, WC. Salivary Gland. In: Cibas, ES, Ducatman, BS, eds. Diagnostic Principles and Clinical Correlated, 3rd edn. Philadelphia: W.B. Saunders, 2009;285–318Google Scholar
Setiawan, VW, Yang, HP, Pike, MC, McCann, SE, Yu, H, Xiang, YB et al. Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 2013;31:2607–18CrossRefGoogle ScholarPubMed
Hoyo, C, Cook, MB, Kamangar, F, Freedman, ND, Whiteman, DC, Bernstein, L et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol 2012;41:1706–18CrossRefGoogle ScholarPubMed
Chen, Y, Liu, L, Wang, X, Wang, J, Yan, Z, Cheng, J et al. Body mass index and risk of gastric cancer: a meta-analysis of a population with more than ten million from 24 prospective studies. Cancer Epidemiol Biomarkers Prev 2013;22:1395–408CrossRefGoogle ScholarPubMed